Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1186999220 | 11869992 | 20 | F | 20160627 | 20151228 | 20160707 | EXP | GB-ROCHE-1678520 | ROCHE | 0.00 | F | Y | 87.00000 | KG | 20160707 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1186999220 | 11869992 | 1 | PS | AVASTIN | BEVACIZUMAB | 1 | Unknown | U | U | 125085 | |||||||||
| 1186999220 | 11869992 | 2 | SS | AVASTIN | BEVACIZUMAB | 1 | Unknown | UNK | U | U | 125085 | ||||||||
| 1186999220 | 11869992 | 3 | SS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | UNK | U | 20896 | |||||||||
| 1186999220 | 11869992 | 4 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 1186999220 | 11869992 | 5 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | U | U | 0 | |||||||||
| 1186999220 | 11869992 | 6 | SS | RIVAROXABAN | RIVAROXABAN | 1 | Unknown | U | U | 0 | |||||||||
| 1186999220 | 11869992 | 7 | SS | RIVAROXABAN | RIVAROXABAN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 1186999220 | 11869992 | 8 | C | DEXAMETHASON | DEXAMETHASONE | 1 | Unknown | 0 | |||||||||||
| 1186999220 | 11869992 | 9 | C | IRINOTECAN | IRINOTECAN | 1 | Unknown | UNK | 0 | ||||||||||
| 1186999220 | 11869992 | 10 | C | LOPERAMIDE | LOPERAMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 1186999220 | 11869992 | 11 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 1186999220 | 11869992 | 12 | C | ONDANSETRON | ONDANSETRON | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1186999220 | 11869992 | 1 | Product used for unknown indication |
| 1186999220 | 11869992 | 2 | Product used for unknown indication |
| 1186999220 | 11869992 | 3 | Product used for unknown indication |
| 1186999220 | 11869992 | 4 | Product used for unknown indication |
| 1186999220 | 11869992 | 5 | Product used for unknown indication |
| 1186999220 | 11869992 | 6 | Product used for unknown indication |
| 1186999220 | 11869992 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1186999220 | 11869992 | HO |
| 1186999220 | 11869992 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1186999220 | 11869992 | Abdominal mass | |
| 1186999220 | 11869992 | Abdominal pain | |
| 1186999220 | 11869992 | Back pain | |
| 1186999220 | 11869992 | Balance disorder | |
| 1186999220 | 11869992 | Blood pressure increased | |
| 1186999220 | 11869992 | Blood urine present | |
| 1186999220 | 11869992 | Catheter site bruise | |
| 1186999220 | 11869992 | Cold sweat | |
| 1186999220 | 11869992 | Confusional state | |
| 1186999220 | 11869992 | Constipation | |
| 1186999220 | 11869992 | Contusion | |
| 1186999220 | 11869992 | Decreased appetite | |
| 1186999220 | 11869992 | Diarrhoea | |
| 1186999220 | 11869992 | Discomfort | |
| 1186999220 | 11869992 | Dizziness | |
| 1186999220 | 11869992 | Dry skin | |
| 1186999220 | 11869992 | Dysgeusia | |
| 1186999220 | 11869992 | Dysgraphia | |
| 1186999220 | 11869992 | Dyspnoea exertional | |
| 1186999220 | 11869992 | Dysuria | |
| 1186999220 | 11869992 | Faeces discoloured | |
| 1186999220 | 11869992 | Fall | |
| 1186999220 | 11869992 | Fatigue | |
| 1186999220 | 11869992 | Feeling hot | |
| 1186999220 | 11869992 | Fine motor skill dysfunction | |
| 1186999220 | 11869992 | Gastrointestinal inflammation | |
| 1186999220 | 11869992 | Haematuria | |
| 1186999220 | 11869992 | Hallucination | |
| 1186999220 | 11869992 | Hangover | |
| 1186999220 | 11869992 | Hot flush | |
| 1186999220 | 11869992 | Hyperhidrosis | |
| 1186999220 | 11869992 | Hypoaesthesia | |
| 1186999220 | 11869992 | Ill-defined disorder | |
| 1186999220 | 11869992 | Intestinal obstruction | |
| 1186999220 | 11869992 | Malaise | |
| 1186999220 | 11869992 | Medical device pain | |
| 1186999220 | 11869992 | Memory impairment | |
| 1186999220 | 11869992 | Menopause | |
| 1186999220 | 11869992 | Middle insomnia | |
| 1186999220 | 11869992 | Motion sickness | |
| 1186999220 | 11869992 | Mouth ulceration | |
| 1186999220 | 11869992 | Muscle spasms | |
| 1186999220 | 11869992 | Nausea | |
| 1186999220 | 11869992 | Neuropathy peripheral | |
| 1186999220 | 11869992 | Night sweats | |
| 1186999220 | 11869992 | Oropharyngeal pain | |
| 1186999220 | 11869992 | Pain | |
| 1186999220 | 11869992 | Pain in extremity | |
| 1186999220 | 11869992 | Pallor | |
| 1186999220 | 11869992 | Palmar-plantar erythrodysaesthesia syndrome | |
| 1186999220 | 11869992 | Paraesthesia | |
| 1186999220 | 11869992 | Pelvic pain | |
| 1186999220 | 11869992 | Peripheral coldness | |
| 1186999220 | 11869992 | Pollakiuria | |
| 1186999220 | 11869992 | Protein urine | |
| 1186999220 | 11869992 | Pulmonary thrombosis | |
| 1186999220 | 11869992 | Renal pain | |
| 1186999220 | 11869992 | Skin fissures | |
| 1186999220 | 11869992 | Sleep disorder | |
| 1186999220 | 11869992 | Somnolence | |
| 1186999220 | 11869992 | Speech disorder | |
| 1186999220 | 11869992 | Temperature intolerance | |
| 1186999220 | 11869992 | Tremor | |
| 1186999220 | 11869992 | Ureteric obstruction | |
| 1186999220 | 11869992 | Urinary retention | |
| 1186999220 | 11869992 | Urinary tract infection | |
| 1186999220 | 11869992 | Vomiting | |
| 1186999220 | 11869992 | Weight decreased | |
| 1186999220 | 11869992 | White blood cells urine positive |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |